je.st
news
Tag: biotech
3 Biotech Stocks You Don't Have to Babysit
2016-03-29 16:00:40| Biotech - Topix.net
Looking for a biotech stock that doesn't require constant monitoring? Our contributors suggest that you take a closer look at these three stocks. Biotech stocks tend to be a risky breed.
Tags: to
stocks
biotech
babysit
Biogen's Newer Problems; Their Relevance To The Biotech Sector
2016-03-28 21:10:47| Biotech - Topix.net
Biogen is running into some potentially serious patent issues with its lead drug Tecfidera, which are discussed in some detail herein. The large-cap biotech Biogen has had some major news break.
Tags: problems
sector
newer
relevance
Stephens Reiterates Buy Rating for Trinity Biotech plc
2016-03-28 08:41:48| Biotech - Topix.net
's stock had its "buy" rating reiterated by equities research analysts at Stephens in a research report issued on Saturday, MarketBeat reports. Several hedge funds and institutional investors recently made changes to their positions in TRIB.
Pressure mounts on biotech industry shill and chemical pesticide...
2016-03-25 11:44:16| Biotech - Topix.net
A public interest watchdog group that focuses on ensuring truth and transparency in America's food system, is calling on a noted corporate Big Food and GMO defender to publicly reveal any sources of funding he receives. U.S. Right To Know , in a recent press release , said that Jon Entine , a top chemical industry PR operative who has churned out scores of articles in defense of various corporate interests, attacked the Columbia School of Journalism in a March 1 New York Post column, claiming it "smeared Exxon," engaged in "advocacy journalism," and hired "an activist" to run the school.
Tags: industry
pressure
chemical
biotech
UPDATE 1-U.S. FDA approves Teva's biotech drug for severe asthma
2016-03-23 21:16:09| Biotech - Topix.net
The U.S. Food and Drug Administration said on Wednesday it had approved Teva Pharmaceutical Industries Ltd's drug to treat asthma in adults who have a history of severe attacks despite taking medication. The drug, Cinqair, part of a new wave of biotech drugs for severe asthma, is administered intravenously every four weeks in combination with other drugs.
Tags: update
drug
severe
biotech
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »